We investigated the functional role of LCN2 in IBC brain metastasis by using our HER2+ MDA‐IBC3 mouse model, which has a high propensity to metastasize to the brain and has been used to identify targets and develop therapeutics against brain metastasis [29, 38, 39, 40]. The gene discussed is LCN2; the disease is inflammatory breast carcinoma.